Veru VERU
NASDAQ VERU
$2.64 +0.06 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Veru (VERU) Cost of Revenue (2012 - 2024)

Veru (VERU) posted quarterly Cost of Revenue of $2.9 million for Q4 2024, up 192.9% year-over-year from $990274.0 in Q1 2024, and down 26.93% quarter-over-quarter from $4.0 million in Q3 2024.

Veru (VERU) Cost of Revenue (2012 - 2024) Analysis & Trends

Veru (VERU) has reported Cost of Revenue for 13 consecutive years, with $2.9 million the latest figure, recorded in Q4 2024.

  • In Q4 2024, Cost of Revenue rose 192.9% year-over-year to $2.9 million; the TTM figure through Sep 2025 stood at $2.9 million (down 73.71% YoY), while the FY2025 annual figure was $2.9 million, down 73.71% from the prior year.
  • Cost of Revenue fell to $2.9 million in Q4 2024 per VERU's latest filing, from $4.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $4.0 million in Q3 2024 and bottomed at $990274.0 in Q4 2023.
  • Historically, Cost of Revenue has averaged $2.7 million across 5 years, with a median of $2.5 million in 2020.
  • Annual changes were most pronounced in 2020 — Cost of Revenue plunged 47.56% — and 2024, when it soared 192.9%.
  • Veru's Cost of Revenue stood at $3.8 million in 2020, then sank by 39.34% to $2.3 million in 2021, then fell by 21.25% to $1.8 million in 2022, then tumbled by 45.16% to $990274.0 in 2023, then jumped by 192.9% to $2.9 million in 2024.
  • Business Quant data shows VERU's Cost of Revenue at $2.9 million in Q4 2024, $4.0 million in Q3 2024, and $2.6 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 489.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 360.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 145.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 93.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 174.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 298.26 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 387.98 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 67.21 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Veru 60.85 Mn 35.06 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.90 Mn
Dec 31, 2024 2.90 Mn
Sep 30, 2024 3.97 Mn
Sep 30, 2024 3.97 Mn
Jun 30, 2024 2.62 Mn
Jun 30, 2024 2.62 Mn
Mar 31, 2024 3.46 Mn
Mar 31, 2024 3.46 Mn
Dec 31, 2023 990,274.00
Dec 31, 2023 990,274.00
Sep 30, 2023 2.32 Mn
Sep 30, 2023 2.32 Mn
Jun 30, 2023 2.11 Mn
Jun 30, 2023 2.11 Mn
Mar 31, 2023 2.49 Mn
Mar 31, 2023 2.49 Mn
Dec 31, 2022 1.81 Mn
Dec 31, 2022 1.81 Mn
Sep 30, 2022 2.08 Mn
Sep 30, 2022 2.08 Mn